Section one: Contracting authority
one.1) Name and addresses
NHS Blood and Transplant
500 North Bristol Park
Bristol
BS34 7QH
Contact
Samantha Rix
Telephone
+44 7385972251
Country
United Kingdom
Region code
UKK11 - Bristol, City of
National registration number
NHS Blood and Transplant
Internet address(es)
Main address
Buyer's address
one.3) Communication
Additional information can be obtained from the above-mentioned address
Electronic communication requires the use of tools and devices that are not generally available. Unrestricted and full direct access to these tools and devices is possible, free of charge, at
https://health-family.force.com/s/Welcome
one.4) Type of the contracting authority
Body governed by public law
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Additive solutions for the Suspension of Blood Products
Reference number
C120135
two.1.2) Main CPV code
- 33194220 - Blood-transfusion supplies
two.1.3) Type of contract
Supplies
two.1.4) Short description
This Prior Information Notice (PIN) is separate to any tender opportunity, its purpose is to consult and gauge interest in the market, to improve NHSBT’s knowledge of 'Additive Solutions for the Suspension of Blood Products' available in the marketplace.
two.1.5) Estimated total value
Value excluding VAT: £5,500,000
two.1.6) Information about lots
This contract is divided into lots: No
two.2) Description
two.2.3) Place of performance
NUTS codes
- UK - United Kingdom
Main site or place of performance
United Kingdom, Ireland, Australia and New Zealand
two.2.4) Description of the procurement
NHS Blood and Transplant (NHSBT) is a Special Health Authority in the NHS and is responsible for the provision of blood components and a range of associated laboratory and patient therapeutic services to hospitals in England.
NHSBT wishes to inform the market of prospective requirements, as far as their details are known at this time for the suspension of apheresis platelets, whole blood derived pooled platelets and specialist red cell products by the establishment of a Framework Agreement with the following Blood Establishments as beneficiaries - NHS Blood and Transplant; the Welsh Blood Service (WBS); the Northern Ireland Blood Transfusion Service (NIBTS); the Scottish National Blood Transfusion Service (SNBTS); the Australian Red Cross Lifeblood (ARCL), the New Zealand Blood Service (NZBS) and the Irish Blood Transfusion Service (IBTS).
Description of the goods to be purchased:
Additive solution for the suspension of platelets, granulocytes and other components derived from whole blood; Additive solution for the suspension of single donor apheresis derived platelets and SAGM solution for the routine washing and re-suspension of red cells during the production of specialist blood products in accordance with the Guidelines for the Blood Transfusion Services in the UK details of which can be found at the following website https://www.transfusionguidelines.org/red-book
Supplier Engagement Meeting(s) via Microsoft TEAMS will be held in late January or early February 2023.
The format of the Supplier Engagement Meeting will be communicated to those organisations that respond to this PIN.
Expressions of interest for the Supplier Engagement activity should be submitted by email to Samantha.rix@nhsbt.nhs.uk no later than 16:00 GMT on 13 January 2023.
two.3) Estimated date of publication of contract notice
1 March 2023
Section four. Procedure
four.1) Description
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: Yes